Cardurion Pharmaceuticals

Yesterday, #OneCardurion celebrated Culture Day (文化の日, Bunka no Hi), a national holiday in Japan dedicated to the promotion of culture, the arts, and academic endeavors. This day also considered a "sunny day" with a high probability of sunny weather. #japanesecultureday

We recently completed the Wellable Biotech Wellness Challenge, and we’re proud that more than half of Cardurion employees participated! This multi-company, global employee wellness program was designed to engage biotech, life sciences and pharma companies of all sizes in a healthy competition to improve team well-being and create a culture of health. Congratulations to our two top challengers, Yasufumi and Jennifer, who both finished in the top 100 out of almost 2,000 participants! #OneCardurion

As we close out the week, we are grateful to all of our employees traveling from near and far to spend time together. Here are a few more pictures of the week, including our happy hour and bowling night! #OneCardurion

We’re thrilled to celebrate the opening of our expanded space in Burlington to support Cardurion’s continued growth, with many team members here in person. #OneCardurion

We're honored that we were just named an #Endpoints11 2024 most promising biotech company. Interested in joining the team? We're hiring! Check out our open roles: https://lnkd.in/gDBjAzUh #CVdruginnovation #JoinOneCardurion

Yesterday, we recognized #WorldHeartDay, advocating for focus on cardiovascular health around the world. We're proud to be working on new treatments for patients with #cardiovasculardisease and #heartfailure. #CVdruginnovation #OneCardurion https://lnkd.in/gwhr3AAA

We had a fabulous time at the #Endpoints11 event last night. We’re honored to be recognized with other great companies and colleagues in the 2024 Endpoints 11 class. #OneCardurion

We’re pleased to share this profile of Cardurion in Endpoints News, recognizing the #Endpoints11 winners. #OneCardurion https://lnkd.in/ejtXNpUQ

We’re honored to be recognized by Endpoints News as an #Endpoints11 2024 most promising biotech startup, for our groundbreaking approach to developing new medicines for patients with #cardiovasculardisease. https://lnkd.in/eBVhsZ5N

Join us in welcoming Ron Renaud to the Cardurion Board of Directors. His 25 years of experience in evaluating, building, and leading biotechnology companies will contribute to our progress as we work to achieve major milestones in heart failure and CPVT and expand our pipeline. https://lnkd.in/ea-pH4vw